Article
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction.
Cardiovascular diabetology - 26 Nov 2025
Pelusi Serena, Macchi Chiara, Malvestiti Francesco, Margarita Sara, De Matteis Irene, Periti Giulia, Rondena Jessica, Mira Stefania, Iemma Francesca, Tranchina Martina, Nardi Barbara, Lucci Carla, Sirtori Cesare R, Millet Oscar, Mato Jose M, Targher Giovanni, Prati Daniele, Ruscica Massimiliano, Valenti Luca
Abstract excerpt
BACKGROUND: The relationship between plasma lipoprotein(a) [Lp(a)] levels and metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear. The aim of this study was to examine the combined effects of Lp(a) levels on liver and vascular damage. METHODS: The study was conducted using the Liver-Bible cohort of individuals with metabolic dysfunction (n = 859, 808 with genomic information) and the...
Read the complete abstract on PubMedTopics
- Humans
- Lipoprotein(a)
- Male
- Female
- Middle Aged